ISDA

Deposition Date 2020-02-27

Release Date 2021-01-13

Last Version Date 2024-10-16

Entry Detail

PDB ID:

6Y6S

Keywords:

HYDROLASE

Title:

Mouse Galactocerebrosidase complexed with galacto-noeurostegine GNS at pH 6.8

Biological Source:

Source Organism:

Mus musculus (Taxon ID: 10090)

Host Organism:

Homo sapiens

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.10 Å

R-Value Free:

0.20

R-Value Work:

0.16

R-Value Observed:

0.16

Space Group:

H 3 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Galactocerebrosidase
Gene (Uniprot):Galc
Chain IDs:A
Chain Length:654
Number of Molecules:1
Biological Source:Mus musculus

UniProt ID:P54818 Pfam ID:PF02057, PF17387, PF21708 EC:3.2.1.46

Ligand Molecules

NAG

ODW

Primary Citation

The Bicyclic Form of galacto -Noeurostegine Is a Potent Inhibitor of beta-Galactocerebrosidase.

Viuff, A, Salamone, S, McLoughlin, J, Deane, J.E, Jensen, H.H.Show

Acs Med.Chem.Lett. 12 56 59 (2021)

PMID: 33488964 DOI: 10.1021/acsmedchemlett.0c00377

Abstact

Competitive inhibitors of galactocerebrosidase (GALC) could be candidates for pharmacological chaperone therapy of patients with Krabbe disease. The known and selective nortropane-type iminosugar galacto-noeurostegine has been found to competitively inhibit GALC with K i = 7 μM at pH 4.6, which is 330-fold more potent than the analogous deoxynoeurostegine. It was shown through X-ray protein crystallography that galacto-noeurostegine binds to the active site of GALC in its bicyclic form.

Legend

Protein

Chemical

Disease

Primary Citation of related structures